Company Name: |
Goodee Pharma Co., Ltd.
|
Tel: |
0512-62956210 |
Email: |
yongyan@goodeepharma.com |
Products Intro: |
Product Name:methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate CAS:251327-00-1 Purity:99% HPLC Package:100g, 1kg
|
Company Name: |
S.Z. PhyStandard Bio-Tech. Co., Ltd.
|
Tel: |
0755-4000505016 13380397412 |
Email: |
3001272453@qq.com |
Products Intro: |
Product Name:Peramivir Impurity 41 Purity:98%HPLC Package:10mg;25mg;50mg;100mg
|
Company Name: |
ShangHai Caerulum Pharma Discovery Co., Ltd.
|
Tel: |
18149758185 18149758185 |
Email: |
sales-cpd@caerulumpharma.com |
Products Intro: |
Product Name:Methyl (4S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-cyclopentene-1-carboxylate CAS:251327-00-1 Purity:98% Package:1g;10g;100g
|
Company Name: |
ChemStrong Scientific Co.,Ltd
|
Tel: |
0755-0755-66853366 13670046396 |
Email: |
sales@chem-strong.com |
Products Intro: |
Product Name:Peramivir Impurity 41 Purity:95% HPLC Package:10mg;25mg;50mg;100mg
|
|
| methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate Basic information |
Product Name: | methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate | Synonyms: | methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate;Peramivir Impurity 41;tube1184;Peramivir impurities 41;Methyl (4S)-4-[[(1,1-dimethylethoxy)carbonyl]amino]-1-cyclopentene-1-carboxylate;1-Cyclopentene-1-carboxylic acid, 4-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl ester, (4S)-;Peramivir Impurity 111 | CAS: | 251327-00-1 | MF: | C12H19NO4 | MW: | 241.28 | EINECS: | | Product Categories: | | Mol File: | 251327-00-1.mol | |
| methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate Chemical Properties |
Boiling point | 340.6±42.0 °C(Predicted) | density | 1.11±0.1 g/cm3(Predicted) | pka | 11.90±0.40(Predicted) |
| methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate Usage And Synthesis |
| methyl (S)-4-((tert-butoxycarbonyl)amino)cyclopent-1-ene-1-carboxylate Preparation Products And Raw materials |
|